0000899797-05-000416 Sample Contracts

EXCLUSIVE TECHNOLOGY LICENSE AGREEMENT BETWEEN PROTEOMTECH, INC. AND Guizhou Yibai Pharmaceutical Company, Ltd
Exclusive Technology License Agreement • December 16th, 2005 • China Rx Holdings, Inc. • California

THIS AGREEMENT ("Agreement") is made and effective as of the date of last signing ("Effective Date") by and between Guizhou Yibai Pharmaceutical Company, Ltd, having a principal place of business at 220-1 Baiyun Rd, Guiyang, Guizhou, China ("Licensee"), and ProteomTech, Inc. ("PTI"), having a principal place of business at 5980 Horton St, Ste 405, Emeryville, CA, 94608, USA.

AutoNDA by SimpleDocs
EXCLUSIVE LICENSE AGREEMENT BETWEEN GEORGETOWN UNIVERSITY AND PROTEOMTECH, INC.
exclusive License Agreement • December 16th, 2005 • China Rx Holdings, Inc. • District of Columbia

Effective as of 4th day of March 2002 ("Effective Date"), GEORGETOWN UNNERSITY, a not-for-profit corporation of the District of Columbia, having a principal address at 37th & 0 Streets, N.W., Washington, D C. 20057 ("Georgetown" or "LICENSOR"), and ProteomTech, Inc., a corporation, having a principal place of business at 800 Research Parkway, Oklahoma City, OK 73104 ("LICENSEE"), agree as follows:

Trademark License Agreement
Trademark License Agreement • December 16th, 2005 • China Rx Holdings, Inc.

According to the regulation of Article 40 of Trademark Law of the People's Republic of China (the "PRC") and Article 43 of Implementing Regulations of Trademark Law, through friendly consultations, Party A and Party B sign this Trademark License Agreement (the "Agreement") in honesty and good faith to clearly define the rights and duties of the two parties.

SHARE TRANSFER AGREEMENT ABOUT TRANSFER OF THE SHARES OF GUIZHOU YIBAI XINGYE PHARMACEUTICAL CO., LTD BETWEEN IST VENTURES LIMITED AND FIRST CAPITAL ASIA INVESTMENT LIMITED JANUARY, 2005 SHARE TRANSFER AGREEMENT
Share Transfer Agreement • December 16th, 2005 • China Rx Holdings, Inc.

THIS SHARE TRANSFER AGREEMENT (hereinafter referred to as "this Agreement") is made and entered into in Guiyang City, Guizhou Province, the People's Republic of China (hereinafter referred to as "China") as of January 4th , 2005 by and among the following two parties:

LICENSE AGREEMENT
License Agreement • December 16th, 2005 • China Rx Holdings, Inc. • Oklahoma

This Agreement is made and entered into as of the 9th day of May, 2001, by and between the OKLAHOMA MEDICAL RESEARCH FOUNDATION, an Oklahoma nonprofit corporation ("OMRF"), 825 N.E. 13th Street, Oklahoma City, Oklahoma 73104; and PROTEOMTECH-YIBAI, INC. ("Licensee"), a corporation duly incorporated under the laws of Delaware, and maintaining offices at 800 Research Parkway, Oklahoma City, Oklahoma 73104.

Amendment of the Exclusive Technology License Agreement
Exclusive Technology License Agreement • December 16th, 2005 • China Rx Holdings, Inc.

The effective date of the exclusive Technology License Agreement (the "Agreement") signed by ProteomTech, Inc. ("PTI") and Guizhou Yibai Pharmaceutical Company, Ltd ("Yibai") on March 7, 2005, is hereby changed from "the date of last signing" to "the date when license fee (defined in 6.1 of the Agreement) is paid by Yibai, or when PTI delivers the Technology (defined in 1.4, 1.5, 1.6, 1.7 of the Agreement) to Yibai, whichever is later".

Time is Money Join Law Insider Premium to draft better contracts faster.